Cita APA

Ammassari, A., Stohr, W., Antinori, A., Molina, J., Schwimmer, C., Domingo, P., . . . Grp, N. A. T. S. (2018). Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.

Citación estilo Chicago

Ammassari, A., et al. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. 2018.

Cita MLA

Ammassari, A., et al. Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. 2018.